相似文献
1
Role of autophagy in drug induced liver injury.
Arch Toxicol. 2020 Oct;94(10):3599-3600. doi: 10.1007/s00204-020-02887-z. Epub 2020 Aug 27.
2
[Amiodarone-induced liver dysfunctions].
Dtsch Med Wochenschr. 2010 Jul;135(27):1372-4. doi: 10.1055/s-0030-1262421. Epub 2010 Jun 29.
3
A case of amiodarone-induced hyperthyroidism and hepatitis: results of clinical laboratory and histological tests.
Biomed Pharmacother. 1986;40(2):54-7.
4
[Amiodarone and liver damage].
Ugeskr Laeger. 1987 May 25;149(22):1470-1.
5
N-acetylcysteine treats intravenous amiodarone induced liver injury.
World J Gastroenterol. 2015 Mar 7;21(9):2816-9. doi: 10.3748/wjg.v21.i9.2816.
6
[Digitalis intoxication in the presence of amiodarone-induced acute hepatitis].
G Ital Cardiol. 1988 Oct;18(10):862-4.
7
Acute amiodarone-induced hepatitis.
Hepatogastroenterology. 1991 Feb;38(1):71-4.
8
Amiodarone-induced liver toxicity.
Ann Intern Med. 1988 Nov 15;109(10):838-40. doi: 10.7326/0003-4819-109-10-838.
9
How toxic is amiodarone to the liver?
J Gastrointestin Liver Dis. 2010 Mar;19(1):11-3.
10
Severe liver toxicity by intravenous amiodarone.
Med Clin (Barc). 2019 Sep 27;153(6):258-259. doi: 10.1016/j.medcli.2018.11.004. Epub 2018 Dec 27.
引用本文的文献
1
essential oil attenuates acetaminophen-induced liver injury through alleviating oxidative stress and activating autophagy.
Pharm Biol. 2022 Dec;60(1):958-967. doi: 10.1080/13880209.2022.2067569.
本文引用的文献
1
Autophagy alleviates amiodarone-induced hepatotoxicity.
Arch Toxicol. 2020 Oct;94(10):3527-3539. doi: 10.1007/s00204-020-02837-9. Epub 2020 Jul 10.
2
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
Arch Toxicol. 2019 Jun;93(6):1609-1637. doi: 10.1007/s00204-019-02492-9. Epub 2019 Jun 27.
3
Toxicogenomics directory of rat hepatotoxicants in vivo and in cultivated hepatocytes.
Arch Toxicol. 2018 Dec;92(12):3517-3533. doi: 10.1007/s00204-018-2352-3. Epub 2018 Dec 3.
4
Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes.
Arch Toxicol. 2018 Dec;92(12):3505-3515. doi: 10.1007/s00204-018-2302-0. Epub 2018 Oct 13.
5
Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal Blood.
Hepatology. 2019 Feb;69(2):666-683. doi: 10.1002/hep.30213. Epub 2018 Nov 19.
6
Adverse outcome pathways: opportunities, limitations and open questions.
Arch Toxicol. 2017 Nov;91(11):3477-3505. doi: 10.1007/s00204-017-2045-3. Epub 2017 Oct 19.
7
In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice.
Arch Toxicol. 2017 Mar;91(3):1335-1352. doi: 10.1007/s00204-016-1906-5. Epub 2016 Dec 20.
8
The ascending pathophysiology of cholestatic liver disease.
Hepatology. 2017 Feb;65(2):722-738. doi: 10.1002/hep.28965.
9
Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases.
J Hepatol. 2016 Apr;64(4):860-71. doi: 10.1016/j.jhep.2015.11.018. Epub 2015 Nov 27.
10
Cholestasis-induced adaptive remodeling of interlobular bile ducts.
Hepatology. 2016 Mar;63(3):951-64. doi: 10.1002/hep.28373. Epub 2016 Jan 14.
Zotero 插件